Molecularly characterised xenograft tumour mouse models: Valuable tools for evaluation of new therapeutic strategies for secondary liver cancers

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Hohenadl, Christine ^a   Mischek, Daniela ^a,b   Steinborn, Ralf ^a   Petznek, Helga ^a   Bichler, Christoph ^c   Zatloukal, Kurt ^d   Stürzl, Michael ^e   Günzburg, Walter H ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CARCINOGENESIS; CELL CULTURE; CELL CYCLE REGULATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; XENOGRAFT; XENOTRANSPLANTATION; ADENOCARCINOMA; AGED; ANIMAL; CANCER TRANSPLANTATION; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MOUSE MUTANT; NONPARAMETRIC TEST; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 65349180755     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/437284     Document Type: Article

References (30)

1. Khan S. A., Davidson B. R., Goldin R., Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 2002 51 supplement 6 vi1 vi9 (Pubitemid 35216840)
2. Lise M., Pilati P., Da Pian P., Mocellin S., Nitti D., Corazzino S., Treatment options for liver metastases from colorectal cancer Journal of Experimental x26; Clinical Cancer Research 2003 22 supplement 4 149 156 (Pubitemid 38436449)
3. Lise M., Mocellin S., Pilati P., Nitti D., Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches Frontiers in Bioscience 2005 10 3042 3057 (Pubitemid 40910543)
4. Saletti P., Cavalli F., Metastatic colorectal cancer Cancer Treatment Reviews 2006 32 7 557 571 (Pubitemid 44478736)
5. Tuveson D. A., Jacks T., Technologically advanced cancer modeling in mice Current Opinion in Genetics and Development 2002 12 1 105 110 (Pubitemid 34094998)
6. Tuveson D. A., Zhu L., Gopinathan A., M i s t 1-K r a s G 12 D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma Cancer Research 2006 66 1 242 247 (Pubitemid 43166030)
7. Kilian M., Gregor J. I., Heukamp I., Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer Investigational New Drugs 2005 23 2 157 164 (Pubitemid 40386233)
8. Anisimov V. N., Ukraintseva S. V., Yashin A. I., Cancer in rodents: does it tell us about cancer in humans? Nature Reviews Cancer 2005 5 10 807 819 (Pubitemid 41408566)
9. Rangarajan A., Weinberg R. A., Comparative biology of mouse versus human cells: modelling human cancer in mice Nature Reviews Cancer 2003 3 12 952 959 (Pubitemid 37500180)
10. Chen Y., Chang K.-J., Hwang L.-H., Chen C.-N., Tseng S.-H., Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy International Journal of Colorectal Disease 2002 17 6 388 395 (Pubitemid 36075787)
11. Paine-Murrieta G. D., Taylor C. W., Curtis R. A., Human tumor models in the severe combined immune deficient (scid) mouse Cancer Chemotherapy and Pharmacology 1997 40 3 209 214 (Pubitemid 27257733)
12. Sun F. X., Tang Z. Y., Liu K. D., Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues International Journal of Cancer 1996 66 2 239 243 (Pubitemid 26248207)
13. Fu X. Y., Besterman J. M., Monosov A., Hoffman R. M., Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens Proceedings of the National Academy of Sciences of the United States of America 1991 88 20 9345 9349
14. Armengol C., Tarafa G., Boix L., Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line Clinical Cancer Research 2004 10 6 2150 2157 (Pubitemid 38375577)
15. Gao Y.-S., Chen X.-P., Li K.-Y., Wu Z.-D., Nude mice model of human hepatocellular carcinoma via orthotopic implantation of histologically intact tissue World Journal of Gastroenterology 2004 10 21 3107 3111 (Pubitemid 39419868)
16. Carlsson G., Gullberg B., HafstrxF6;m L., Estimation of liver tumor volume using different formulasx2014;an experimental study in rats Journal of Cancer Research and Clinical Oncology 1983 105 1 20 23 (Pubitemid 13194363)
17. Kalinichenko V. V., Major M. L., Wang X., Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor Genes x26; Development 2004 18 7 830 850 (Pubitemid 38480894)
18. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-x394;x394;CT method Methods 2001 25 4 402 408 (Pubitemid 34164012)
19. HammarstrxF6;m S., The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Seminars in Cancer Biology 1999 9 2 67 81 (Pubitemid 29265523)
20. Chu P. G., Weiss L. M., Keratin expression in human tissues and neoplasms Histopathology 2002 40 5 403 439 (Pubitemid 34535443)
21. Li A., Varney M. L., Singh R. K., Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials Clinical Cancer Research 2001 7 10 3298 3304 (Pubitemid 32963857)
22. Vu T. H., Werb Z., Matrix metalloproteinases: effectors of development and normal physiology Genes x26; Development 2000 14 17 2123 2133
23. Stetler-Stevenson W. G., Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention The Journal of Clinical Investigation 1999 103 9 1237 1241 (Pubitemid 29218293)
24. Egeblad M., Werb Z., New functions for the matrix metalloproteinases in cancer progression Nature Reviews Cancer 2002 2 3 161 174 (Pubitemid 37328786)
25. Brinckerhoff C. E., Rutter J. L., Benbow U., Interstitial collagenases as markers of tumor progression Clinical Cancer Research 2000 6 12 4823 4830 (Pubitemid 32110426)
26. Benbow U., Schoenermark M. P., Mitchell T. I., A novel host/tumor cell interaction activates matrix metalloproteinase I and mediates invasion through type I collagen The Journal of Biological Chemistry 1999 274 36 25371 25378 (Pubitemid 129531064)
27. Bassed P., Bellocq J. P., Wolf C., A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas Nature 1990 348 6303 699 704 (Pubitemid 120015135)
28. Soumaoro L. T., Uetake H., Takagi Y., Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis Diseases of the Colon x26; Rectum 2006 49 3 392 398
29. Metzl C., Mischek D., Salmons B., GxFC;nzburg W. H., Renner M., Portsmouth D., Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors Journal of Virology 2006 80 14 7070 7078 (Pubitemid 44025204)
30. Iwasaki Y., Ueda M., Yamada T., Gene therapy of liver tumors with human liver-specific nanoparticles Cancer Gene Therapy 2007 14 1 74 81